A citation-based method for searching scientific literature

Le Xiao, Xuequan Zhu, Amy Gillespie, Yuan Feng, Jingjing Zhou, Xu Chen, Yuanyuan Gao, Xueyi Wang, Xiancang Ma, Chengge Gao, Yunshi Xie, Xiaoping Pan, Yan Bai, Xiufeng Xu, Gang Wang, Runsen Chen. Psychol Med 2021
Times Cited: 6







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Pierre Blier, Herbert E Ward, Philippe Tremblay, Louise Laberge, Chantal Hébert, Richard Bergeron. Am J Psychiatry 2010
190
50

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Pierre Blier, Gabriella Gobbi, Julie E Turcotte, Claude de Montigny, Nathalie Boucher, Chantal Hébert, Guy Debonnel. Eur Neuropsychopharmacol 2009
102
50

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
Linda L Carpenter, Sarah Yasmin, Lawrence H Price. Biol Psychiatry 2002
165
33

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
33

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response.
Nadine Dreimüller, Klaus Lieb, André Tadić, Jan Engelmann, Daniel Wollschläger, Stefanie Wagner. J Affect Disord 2019
19
16

Excess body weight as a predictor of response to treatment with antidepressants in patients with depressive disorder.
Svetlana Puzhko, Sarah A E Aboushawareb, Irina Kudrina, Tibor Schuster, Tracie A Barnett, Christel Renoux, Gillian Bartlett. J Affect Disord 2020
9
16


Body mass index and response to antidepressants in depressed research subjects.
Nader Oskooilar, Charles S Wilcox, My-Linh Tong, Daniel E Grosz. J Clin Psychiatry 2009
31
16

Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders.
Rodrigo B Mansur, Elisa Brietzke, Roger S McIntyre. Neurosci Biobehav Rev 2015
173
16

Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Rudolf Uher, Ole Mors, Joanna Hauser, Marcella Rietschel, Wolfgang Maier, Dejan Kozel, Neven Henigsberg, Daniel Souery, Anna Placentino, Nader Perroud,[...]. J Affect Disord 2009
70
16

Obesity and major depression: Body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations.
Nils Opel, Ronny Redlich, Dominik Grotegerd, Katharina Dohm, Walter Heindel, Harald Kugel, Volker Arolt, Udo Dannlowski. Psychoneuroendocrinology 2015
81
16

Overweight and obesity affect treatment response in major depression.
Stefan Kloiber, Marcus Ising, Simone Reppermund, Sonja Horstmann, Tatjana Dose, Matthias Majer, Josef Zihl, Hildegard Pfister, Paul G Unschuld, Florian Holsboer,[...]. Biol Psychiatry 2007
140
16

Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012-2015.
Linfeng Zhang, Zengwu Wang, Xin Wang, Zuo Chen, Lan Shao, Ye Tian, Congyi Zheng, Suning Li, Manlu Zhu, Runlin Gao. Obes Res Clin Pract 2020
40
16

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.
Floriana S Luppino, Leonore M de Wit, Paul F Bouvy, Theo Stijnen, Pim Cuijpers, Brenda W J H Penninx, Frans G Zitman. Arch Gen Psychiatry 2010
16

Overweight and Obesity Associated with Higher Depression Prevalence in Adults: A Systematic Review and Meta-Analysis.
Emile Pereira-Miranda, Priscila R F Costa, Valterlinda A O Queiroz, Marcos Pereira-Santos, Mônica L P Santana. J Am Coll Nutr 2017
120
16


The interface of depression and obesity.
Nattinee Jantaratnotai, Kanokwan Mosikanon, Yena Lee, Roger S McIntyre. Obes Res Clin Pract 2017
115
16

Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study.
Ellen B Dennehy, Rebecca L Robinson, Judith J Stephenson, Douglas Faries, Michael Grabner, Swetha Rao Palli, Virginia L Stauffer, Lauren B Marangell. Curr Med Res Opin 2015
25
16

Potential role of mirtazapine in underweight older adults.
Olga Hilas, Carmela Avena-Woods. Consult Pharm 2014
8
16

Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
Raquel Iniesta, Karim Malki, Wolfgang Maier, Marcella Rietschel, Ole Mors, Joanna Hauser, Neven Henigsberg, Mojca Zvezdana Dernovsek, Daniel Souery, Daniel Stahl,[...]. J Psychiatr Res 2016
83
16

Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Manish K Jha, Shereen Wakhlu, Neha Dronamraju, Abu Minhajuddin, Tracy L Greer, Madhukar H Trivedi. J Affect Disord 2018
33
16

Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.
Ching-Hua Lin, Cheng-Chung Chen, Julielynn Wong, Roger S McIntyre. J Affect Disord 2014
29
16

Depression and obesity: evidence of shared biological mechanisms.
Yuri Milaneschi, W Kyle Simmons, Elisabeth F C van Rossum, Brenda Wjh Penninx. Mol Psychiatry 2019
256
16

Obesity among outpatients with major depressive disorder.
George I Papakostas, Timothy Petersen, Dan V Iosifescu, Alana M Burns, Andrew A Nierenberg, Jonathan E Alpert, Jerrold F Rosenbaum, Maurizio Fava. Int J Neuropsychopharmacol 2005
66
16

The lack of association between components of metabolic syndrome and treatment resistance in depression.
Marina Sagud, Alma Mihaljevic-Peles, Suzana Uzun, Bjanka Vuksan Cusa, Oliver Kozumplik, Suzan Kudlek-Mikulic, Maja Mustapic, Ivan Barisic, Dorotea Muck-Seler, Nela Pivac. Psychopharmacology (Berl) 2013
22
16


Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
Frank P Bymaster, Wei Zhang, Petra A Carter, Janice Shaw, Eyassu Chernet, Lee Phebus, David T Wong, Kenneth W Perry. Psychopharmacology (Berl) 2002
250
16



Development of beta-adrenergic receptor subsensitivity by antidepressants.
S P Banerjee, L S Kung, S J Riggi, S K Chanda. Nature 1977
697
16




Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety.
Jesse W Richardson-Jones, Caryne P Craige, Thanh H Nguyen, Hank F Kung, Alain M Gardier, Alex Dranovsky, Denis J David, Bruno P Guiard, Sheryl G Beck, René Hen,[...]. J Neurosci 2011
142
16

Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone.
L J Sim-Selley, L J Vogt, R Xiao, S R Childers, D E Selley. Eur J Pharmacol 2000
46
16





Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving rats.
O Curet, G Damoiseau, J P Labaune, V Rovel, F X Jarreau. J Neural Transm Suppl 1994
13
16

Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Daisuke Mochizuki, Ryuichi Tsujita, Shinji Yamada, Koh Kawasaki, Yuji Otsuka, Shinji Hashimoto, Tsuyoshi Hattori, Yoshihisa Kitamura, Naomasa Miki. Psychopharmacology (Berl) 2002
82
16

Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.
J P Finberg, K Pacak, I J Kopin, D S Goldstein. Naunyn Schmiedebergs Arch Pharmacol 1993
31
16




Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice.
Catarina A Owesson, Sarah E Hopwood, Luis F Callado, Isabelle Seif, Daniel P McLaughlin, Jonathan A Stamford. Eur J Neurosci 2002
21
16


Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien, H Gozlan. J Pharmacol Exp Ther 1994
105
16

α1- and β3-Adrenergic Receptor-Mediated Mesolimbic Homeostatic Plasticity Confers Resilience to Social Stress in Susceptible Mice.
Hongxing Zhang, Dipesh Chaudhury, Alexander R Nectow, Allyson K Friedman, Song Zhang, Barbara Juarez, He Liu, Madeline L Pfau, Hossein Aleyasin, Cheng Jiang,[...]. Biol Psychiatry 2019
35
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.